PainChek

PainChek ROA

The Return on Assets (ROA) of PainChek (PCK.AX) as of Oct 26, 2026 is -117.14 %. In the previous year, Return on Assets (ROA) was -356.90 % — a change of -67.18% (higher).

ROA

-117.14 %

YoY

-67.18%

Last updated:

In 2026, PainChek's return on assets (ROA) was -117.14 %, a -67.18% increase from the -356.90 % ROA in the previous year.

The PainChek ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
-68.69 AUD
Jan 1, 2020
-199.38 AUD
Jan 1, 2021
-51.34 AUD
Jan 1, 2022
-85.99 AUD
Jan 1, 2023
-270.99 AUD
Jan 1, 2024
-198.65 AUD
Jan 1, 2025
-356.90 AUD
Jan 1, 2026
-117.14 AUD
The PainChek ROA history
YEARROAYoY
-117.14 %-67.18%
-356.90 %+79.66%
-198.65 %-26.69%
-270.99 %+215.13%
-85.99 %+67.50%
-51.34 %-74.25%
-199.38 %+190.25%
-68.69 %-47.56%
-130.98 %-58.42%
-315.04 %-92.84%
-4,401.14 %+5,936.72%
-72.91 %-11.67%
-82.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

ROA Details

Understanding PainChek's Return on Assets (ROA)

PainChek's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing PainChek's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider PainChek's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in PainChek’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about PainChek stock

Return on Assets (ROA) of PainChek is -117.14 % in 2026.

Return on Assets (ROA) of PainChek changed from -356.90 % to -117.14 %, representing a -67.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) PainChek since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s PainChek with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — PainChek

All Key Metrics — PainChek